Single-cell profiling guided combinatorial immunotherapy for fast-evolving CDK4/6 inhibitor-resistant HER2-positive breast cancer

Journal: Nature Communications

Published: 2019-08-23

DOI: 10.1038/s41467-019-11729-1

Affiliations: 3

Authors: 7

Go to article
Institutions Share
Department of Biological Sciences, ND, United States of America (USA) 0.45
Mike and Josie Harper Cancer Research Institute (HCRI), United States of America (USA) 0.45
Melvin and Bren Simon Cancer Center (IUSCC), IUPUI, United States of America (USA) 0.10